Ardigen took part in Bio-Europe Conference in Berlin

Topic:

BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies.

BIO-Europe’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.

More about Bio-Europe

Ardigen’s attendance at this conference is subsidized with the funds from the ProBio Małopolska project, which is co-financed by the European Union under the European Regional Development Fund, carried out on the basis of the project co-financing agreement No. RPMP.03.03.01-12-0121 / 16-00. The trip is organized with the assistance of Klaster LifeScience Kraków.

You might be also interested in:

AI-powered bioinformatics platform visualizing biological data and model insights in a laboratory setting
The invisible bridge: How UX design can support AI success in bioinformatics?
Biotech AI data privacy in AI-driven biological and pharmaceutical research
Data Privacy Day 2026: Why Data Privacy Is Becoming a Technical Constraint in Biotech AI
Good AI practice is no longer optional in Drug Discovery – EMA and FDA set the direction
From Public Repositories to Target Hypotheses – An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!